Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the
J.P. Morgan 31st Annual Healthcare Conference on January 7,
2013, at 10:00 a.m. ET in San Francisco, CA. A live webcast of this
Infinity presentation will be accessible on the Investors/Media section
of Infinity's website at www.infi.com,
and will be available for 30 days following the event.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative drug discovery and development company seeking
to discover, develop and deliver to patients best-in-class medicines for
diseases with significant unmet need. Infinity combines proven
scientific expertise with a passion for developing novel small molecule
drugs that target emerging disease pathways. Infinity’s programs focused
on the inhibition of phosphoinositide-3-kinase and heat shock protein 90
are evidence of its innovative approach to drug discovery and
development. For more information on Infinity, please refer to the
company’s website at www.infi.com.